首页> 外文期刊>Journal of Medicinal Chemistry >Structure-Activity Relationships at Monoamine Transporters for a Series of N-Substituted 3α-(Bis[4-fluorophenyl]methoxy)tropanes: Comparative Molecular Field Analysis, Synthesis, and Pharmacological Evaluation
【24h】

Structure-Activity Relationships at Monoamine Transporters for a Series of N-Substituted 3α-(Bis[4-fluorophenyl]methoxy)tropanes: Comparative Molecular Field Analysis, Synthesis, and Pharmacological Evaluation

机译:一系列N取代的3α-(双[4-氟苯基]甲氧基)托烷在单胺转运蛋白上的结构活性关系:比较分子场分析,合成和药理评价。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The development of structure-activity relationships (SAR) with divergent classes of monoamine transporter ligands and comparison of their effects in animal models of cocaine abuse have provided insight into the complex relationship among structure, binding profiles, and behavioral activity. Many 3-(diphenylmethoxy)tropane (benztropine) analogues are potent dopamine uptake inhibitors but exhibit behavioral profiles that differ from those of cocaine and other compounds in this class. One of the most potent and dopamine transporter (DAT) selective N-substituted benztropine analogues (N-(4-phenyl-n-butyl)-3-(bis[4-fluorophenyl]methoxy)tropane, 1c) is devoid of cocaine-like behaviors in rodent models but is also highly lipophilic (cLogD = 5.01), which compromises its water solubility and may adversely affect its pharmacokinetic properties. To further explore the SAR in this series and ultimately to design dopamine uptake inhibitors with favorable lipophilicities for drug development, a comparative molecular field analysis (CoMFA) was performed on a set of benztropine analogues previously synthesized in our laboratory. The CoMFA field analysis on the statistically significant (r_(cv)~2 = 0.632; r_(ncv)~2 = 0.917) models provided valuable insight into the structural features required for optimal binding to the DAT, which was used to design a series of novel benztropine analogues with heteroatom substitutions at the tropane N-8. These compounds were evaluated for binding at DAT, serotonin (SERT) and norepinephrine (NET) transporters, and muscarinic M1 receptors in rat brain. Inhibition of [~3H]DA uptake in synaptosomes was also evaluated. Most of the analogues showed high DAT affinity (12-50 nM), selectivity (10- to 120-fold), potent inhibition of dopamine uptake, and lower lipophilicities as predicted by cLogD values.
机译:与不同种类的单胺转运蛋白配体的结构-活性关系(SAR)的发展以及它们在可卡因滥用动物模型中的作用比较,为深入了解结构,结合特征和行为活性之间的复杂关系提供了见识。许多3-(二苯基甲氧基)托烷(苯并卓平)类似物是有效的多巴胺摄取抑制剂,但表现出的行为特征与可卡因和此类中的其他化合物不同。最有效和多巴胺转运蛋白(DAT)的一种选择性N-取代的苯氧平类似物(N-(4-苯基-正丁基)-3-(双[4-氟苯基]甲氧基)托烷,1c)不含可卡因-类似于啮齿动物模型中的行为,但也具有高度亲脂性(cLogD = 5.01),这会损害其水溶性并可能对其药代动力学特性产生不利影响。为了进一步探索该系列中的SAR并最终设计出具有良好亲脂性的多巴胺摄取抑制剂以进行药物开发,对先前在我们实验室中合成的一组苯甲平类似物进行了比较分子场分析(CoMFA)。对具有统计意义的(r_(cv)〜2 = 0.632; r_(ncv)〜2 = 0.917)模型进行CoMFA现场分析,为深入了解与DAT最佳结合所需的结构特征提供了宝贵的见识,该数据用于设计一系列在托烷N-8上具有杂原子取代的新型苯并品平类似物。评估了这些化合物在大鼠大脑中的DAT,血清素(SERT)和去甲肾上腺素(NET)转运蛋白以及毒蕈碱M1受体的结合。还评估了突触小体中[〜3H] DA摄取的抑制作用。如cLogD值所预测,大多数类似物显示出高DAT亲和力(12-50 nM),选择性(10-120倍),对多巴胺摄取的有效抑制以及较低的亲脂性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号